At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 51 enrolled
Drug / intervention
Peanut +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Role of the Microbiome in Blood Glucose Regulation in Response to Peanut Consumption
In Brief
A Phase 2 clinical trial evaluating Peanut and High carbohydrate snack for Type2 Diabetes and Cardiovascular Diseases. Completed, enrolled 51 participants across 1 site.
Detailed Summary
A two-period randomized crossover study will be conducted to determine the effect of peanuts on glycemic control, and elucidate the role of the microbiome in glucose regulation, in individuals with impaired fasting glucose.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType2 Diabetes, Cardiovascular Diseases
CountriesUnited States
CollaboratorsThe Peanut Institute
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartOct 2018
Primary CompletionDec 2019
TodayJul 2026
First PostedAug 31, 2018
Enrollment StartOct 1, 2018
Primary CompletionDec 20, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.8 years ago
Interventions
Peanutdrug
Roasted, unsalted peanuts will be purchased from a local grocery store and provided to subjects to consume.
High carbohydrate snackdrug
Whole wheat crackers will be purchased from a local grocery store and provided to subjects to consume with a spread (e.g. cream cheese or margarine).